An Engineered Multicomponent Bone Marrow Niche for the Recapitulation of Hematopoiesis at Ectopic Transplantation Sites

Overview

Journal J Hematol Oncol

Publisher Biomed Central

Specialties Hematology
Oncology

Date 2016 Jan 27

PMID 26810307

Citations 18

Authors

Monica S Ventura Ferreira

Christian Bergmann

Isabelle Bodensiek

Kristina Peukert

Jessica Abert

Rafael Kramann

Paul Kachel

Bjorn Rath

Stephan Rutten

Ruth Knuchel

Benjamin L Ebert

Horst Fischer

Tim H Brummendorf

Rebekka K Schneider

Affiliations

Soon will be listed here.

Abstract

Background: Bone marrow (BM) niches are often inaccessible for controlled experimentation due to their difficult accessibility, biological complexity, and three-dimensional (3D) geometry.

Methods: Here, we report the development and characterization of a BM model comprising of cellular and structural components with increased potential for hematopoietic recapitulation at ectopic transplantation sites. Cellular components included mesenchymal stromal cells (MSCs) and hematopoietic stem and progenitor cells (HSPCs). Structural components included 3D β-tricalcium phosphate (β-TCP) scaffolds complemented with Matrigel or collagen I/III gels for the recreation of the osteogenic/extracellular character of native BM.

Results: In vitro, β-TCP/Matrigel combinations robustly maintained proliferation, osteogenic differentiation, and matrix remodeling capacities of MSCs and maintenance of HSPCs function over time. In vivo, scaffolds promoted strong and robust recruitment of hematopoietic cells to sites of ectopic transplantation, vascularization, and soft tissue formation.

Conclusions: Our tissue-engineered BM system is a powerful tool to explore the regulatory mechanisms of hematopoietic stem and progenitor cells for a better understanding of hematopoiesis in health and disease.

Citing Articles

Three-dimensional in vitro model of bone metastases of neuroblastoma as a tool for pharmacological evaluations.

Aveic S, Seidelmann M, Davtalab R, Corallo D, Vogt M, Rutten S Nanotheranostics. 2024; 8(1):1-11.

PMID: 38164505 PMC: 10750120. DOI: 10.7150/ntno.85439.

In Vitro Models of Bone Marrow Remodelling and Immune Dysfunction in Space: Present State and Future Directions.

Sarkar R, Pampaloni F Biomedicines. 2022; 10(4).

PMID: 35453515 PMC: 9031916. DOI: 10.3390/biomedicines10040766.

Skeletal Stem Cells as the Developmental Origin of Cellular Niches for Hematopoietic Stem and Progenitor Cells.

Ambrosi T, Chan C Curr Top Microbiol Immunol. 2021; 434:1-31.

PMID: 34850280 PMC: 8864730. DOI: 10.1007/978-3-030-86016-5_1.

The extracellular matrix of hematopoietic stem cell niches.

Lee-Thedieck C, Schertl P, Klein G Adv Drug Deliv Rev. 2021; 181:114069.

PMID: 34838648 PMC: 8860232. DOI: 10.1016/j.addr.2021.114069.

Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches.

Garcia-Garcia A, Klein T, Born G, Hilpert M, Scherberich A, Lengerke C Proc Natl Acad Sci U S A. 2021; 118(40).

PMID: 34580200 PMC: 8501773. DOI: 10.1073/pnas.2114227118.

References

Tibes R, Al-Kali A, Oliver G, Delman D, Hansen N, Bhagavatula K . The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia. J Hematol Oncol. 2015; 8:114. PMC: 4615363. DOI: 10.1186/s13045-015-0211-8. View

Naveiras O, Nardi V, Wenzel P, Hauschka P, Fahey F, Daley G . Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009; 460(7252):259-63. PMC: 2831539. DOI: 10.1038/nature08099. View

Schneider R, Adema V, Heckl D, Jaras M, Mallo M, Lord A . Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. Cancer Cell. 2014; 26(4):509-20. PMC: 4199102. DOI: 10.1016/j.ccr.2014.08.001. View

Schneider R, Puellen A, Kramann R, Raupach K, Bornemann J, Knuechel R . The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials. 2009; 31(3):467-80. DOI: 10.1016/j.biomaterials.2009.09.059. View

Petite H, Viateau V, Bensaid W, Meunier A, de Pollak C, Bourguignon M . Tissue-engineered bone regeneration. Nat Biotechnol. 2000; 18(9):959-63. DOI: 10.1038/79449. View

Walsh W, Vizesi F, Michael D, Auld J, Langdown A, Oliver R . Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials. 2007; 29(3):266-71. DOI: 10.1016/j.biomaterials.2007.09.035. View

Khan Y, Yaszemski M, Mikos A, Laurencin C . Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am. 2008; 90 Suppl 1:36-42. DOI: 10.2106/JBJS.G.01260. View

Chen Y, Jacamo R, Shi Y, Wang R, Battula V, Konoplev S . Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment. Blood. 2012; 119(21):4971-80. PMC: 3367899. DOI: 10.1182/blood-2011-11-389957. View

Lo Celso C, Lin C, Scadden D . In vivo imaging of transplanted hematopoietic stem and progenitor cells in mouse calvarium bone marrow. Nat Protoc. 2011; 6(1):1-14. PMC: 3382040. DOI: 10.1038/nprot.2010.168. View

10.

Fielding G, Bandyopadhyay A, Bose S . Effects of silica and zinc oxide doping on mechanical and biological properties of 3D printed tricalcium phosphate tissue engineering scaffolds. Dent Mater. 2011; 28(2):113-22. PMC: 3259206. DOI: 10.1016/j.dental.2011.09.010. View

11.

Jeong J, Levine M, Abayasekara N, Berliner N, Laubach J, Vanasse G . The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma. J Hematol Oncol. 2015; 8:37. PMC: 4405817. DOI: 10.1186/s13045-015-0136-2. View

12.

Wang X, Ni Q . Determination of cortical bone porosity and pore size distribution using a low field pulsed NMR approach. J Orthop Res. 2003; 21(2):312-9. DOI: 10.1016/S0736-0266(02)00157-2. View

13.

Murphy C, Haugh M, OBrien F . The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials. 2009; 31(3):461-6. DOI: 10.1016/j.biomaterials.2009.09.063. View

14.

Hughes C, Postovit L, Lajoie G . Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics. 2010; 10(9):1886-90. DOI: 10.1002/pmic.200900758. View

15.

Mortera-Blanco T, Mantalaris A, Bismarck A, Aqel N, Panoskaltsis N . Long-term cytokine-free expansion of cord blood mononuclear cells in three-dimensional scaffolds. Biomaterials. 2011; 32(35):9263-70. DOI: 10.1016/j.biomaterials.2011.08.051. View

16.

Schnider J, Weinstock M, Plock J, Solari M, Venkataramanan R, Zheng X . Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential. Clin Dev Immunol. 2013; 2013:495212. PMC: 3586464. DOI: 10.1155/2013/495212. View

17.

Torisawa Y, Spina C, Mammoto T, Mammoto A, Weaver J, Tat T . Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro. Nat Methods. 2014; 11(6):663-9. DOI: 10.1038/nmeth.2938. View

18.

von Doernberg M, von Rechenberg B, Bohner M, Grunenfelder S, van Lenthe G, Muller R . In vivo behavior of calcium phosphate scaffolds with four different pore sizes. Biomaterials. 2006; 27(30):5186-98. DOI: 10.1016/j.biomaterials.2006.05.051. View

19.

Schneider R, Anraths J, Kramann R, Bornemann J, Bovi M, Knuchel R . The role of biomaterials in the direction of mesenchymal stem cell properties and extracellular matrix remodelling in dermal tissue engineering. Biomaterials. 2010; 31(31):7948-59. DOI: 10.1016/j.biomaterials.2010.07.003. View

20.

Taniguchi N, Fujibayashi S, Takemoto M, Sasaki K, Otsuki B, Nakamura T . Effect of pore size on bone ingrowth into porous titanium implants fabricated by additive manufacturing: An in vivo experiment. Mater Sci Eng C Mater Biol Appl. 2015; 59:690-701. DOI: 10.1016/j.msec.2015.10.069. View